11 Cases of Pseudomyxoma Peritonei.
- Author:
Se Kyu KIM
;
Kwang Hyub HAN
;
Ki Baik HAHM
;
Chae Yoon CHON
;
Sang In LEE
;
In Suh PARK
;
Heung Jai CHOI
- Publication Type:Original Article
- MeSH:
Abdominal Pain;
Appendiceal Neoplasms;
Appendix;
Cecal Neoplasms;
Cisplatin;
Constipation;
Cyclophosphamide;
Cystadenocarcinoma;
Cystadenoma, Mucinous;
Dactinomycin;
Defecation;
Diarrhea;
Doxorubicin;
Drug Therapy;
Female;
Fever;
Fluorouracil;
Gastric Bypass;
Gelatin;
Hemorrhage;
Humans;
Lomustine;
Male;
Mucins;
Mucocele;
Nausea;
Ovarian Neoplasms;
Ovariectomy;
Ovary;
Pseudomyxoma Peritonei*;
Rectal Neoplasms;
Rupture;
Stomach Neoplasms;
Weight Loss
- From:Korean Journal of Gastrointestinal Endoscopy
1987;7(1):97-106
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pseudomyxoma peritonei is a rare disorder chracterized by abdominal distension resulting from the accumulation of a mucinous, gelatinous, translucent material which arises from rupture of pre-existing mucinous cystadenomas and cystadenocarcinomas of the ovary and mucocele of the appendix. We report 11 cases of pseudomyxoma peritonei which were diagnosed by surgical and pathological findings. The results were as follows. 1) The mean age of 11 cases was 51 years and 5 cases were male and 6 cases were female and male to female ratio was 1 to 1.2. 2) Clinical manifestations in 11 cases were abdominal distension in 5 cases (45.5%), palpable mass in 4 cases(36.6%), abdominal pain in 4 cases(36.6%), nausea in 3 cases(27.3%), weight loss in 3 cases(27.3%), diarrhea in 2 cases(18.2%), constipation in 1 case(9.0%), anal bleeding in 1 case(9.0%) and defecation difficulty in 1 case(9.0%). The duration of symptoms was 2 days to 1 year. 3) The primary sites of pseudomyxoma peritonei were ovarian cancer in 3 cases(27.2%), appendiceal cancer in 2 cases(18.2%), gastric cancer in 2 cases(18.2%), rectal cancer in 1 case(9.1%), cecal cancer in 1 case(9.1%) and unknown origin in 2 cases(18.2%). 4) Following surgical interventions were performed; right hemicolectomy in 2 cases, palliative gastrojejunostomy in 2 cases, oophorectomy in 1 case, omentectomy in 1 case and right hemicolectomy with gastrojejunostomy in 1 case. 5) The adjunctive anti-cancer chemotherapy was done in 4 cases(36.4%) by combination of actinomycin D, adriamycin, CCNU, cisplatin, cytoxan and fluorouracil, And chemotherapy only was done in 2 cases and hyperthermia was done in 1 case.
